Usana Health Sciences Inc
USNA- Exchange
- NYSE
- Industry
- Medicinal Chemicals & Botanical Products
- SEC CIK
- 0000896264
No open-market purchases or sales by Usana Health Sciences Inc insiders were filed in the last 90 days; 137 institutions reported holding it in 13F filings for Q2 2026, worth $243.0M in total; no superinvestor holds it.
Q2 2025 vs. Q1 2025
How the institutions holding Usana Health Sciences Inc changed between Q1 2025 and Q2 2025.
All holders in Q2 2025All holders in Q1 2025
| Measure | Q1 2025 | Of which not filed for Q2 2025 | Q2 2025 | Change |
|---|---|---|---|---|
| Holders | 162 | 1 | 165 | +4 |
| Shares | 10.8M | 34 | 11.0M | +259.8K (+2.4%) |
| Value | $290.0M | $917 | $336.2M | +$46.2M (+15.9%) |
1 institution that held it in Q1 2025 haven't filed for Q2 2025 yet. Not filing isn't selling, so the changes leave them out.
New holders (31)
Institutions that held Usana Health Sciences Inc at the end of Q2 2025 but not at the end of Q1 2025.
Sold out (27)
Institutions that held Usana Health Sciences Inc at the end of Q1 2025 and filed for Q2 2025 without it.
| Institution | Shares, Q1 2025 | Value, Q1 2025 |
|---|---|---|
| HRT Financial LP | 47,168 | $1.27M |
| ExodusPoint Capital Management, LP | 40,572 | $1.09M |
| Engineers Gate Manager LP | 34,241 | $923.5K |
| AXA S.A. | 34,061 | $918.6K |
| Aviva PLC | 19,933 | $537.6K |
| Dark Forest Capital Management LP | 18,760 | $506.0K |
| Robeco Institutional Asset Management B.V. | 18,223 | $491.5K |
| Counterpoint Mutual Funds LLC | 15,621 | $421.3K |
| Panagora Asset Management Inc | 14,628 | $394.5K |
| Petrus Trust Company, LTA | 13,411 | $361.7K |
| Sherbrooke Park Advisers LLC | 12,509 | $337.4K |
| XTX Topco Ltd | 10,449 | $281.8K |
| Marshall Wace, LLP | 9,986 | $269.3K |
| Nebula Research & Development LLC | 9,069 | $244.6K |
| Graham Capital Management, L.P. | 8,501 | $229.3K |
| Corebridge Financial, Inc. | 5,943 | $160.3K |
| Amundi | 3,986 | $101.5K |
| Coldstream Capital Management Inc | 357 | $9.63K |
| Continuum Advisory, LLC | 190 | $5.12K |
| Quarry LP | 129 | $3.48K |
| TD Waterhouse Canada Inc. | 90 | $2.45K |
| Macquarie Group Ltd | 78 | $2.10K |
| Boston Private Wealth LLC | 77 | $2.08K |
| Headlands Technologies LLC | 43 | $1.16K |
| True Wealth Design, LLC | 4 | $108 |
| Larson Financial Group LLC | 2 | $54 |
| Avion Wealth | 14 | $0 |
Not filed for Q2 2025 yet (1)
Institutions that held Usana Health Sciences Inc at the end of Q1 2025 and haven't filed a 13F for Q2 2025. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q1 2025 | Value, Q1 2025 |
|---|---|---|
| Lindbrook Capital, LLC | 34 | $917 |